Sun Pharmaceutical Industries Ltd. has received a communication from the USFDA indicating that the Halol facility has been classified as “Official Action Indicated” (OAI). The OAI classification implies that the USFDA may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved. The Company continues to manufacture and distribute existing products for the US market, thereby not likely to have any adverse impact on current business from the facility.
Sun Pharma continues to cooperate with the USFDA and will undertake all necessary steps to resolve these issues and to ensure that the regulator is completely satisfied with the Company’s remedial action.
Sun Pharma remains committed to being cGMP compliant and in supplying high-quality products to its customers and patients globally.
Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at Rs.338.2 as compared to the previous close of Rs. 338.55. The total number of shares traded during the day was 288024 in over 5774 trades.
The stock hit an intraday high of Rs. 352 and intraday low of 333.05. The net turnover during the day was Rs. 98223444.-Equity Bulls